Enhanced level of vascular ROS in diabetic patients with dyslipidemia was found to be associated with increased expression and activity of cyclooxygenase-2 (COX-2) leading to secretion of prostaglandin E2 (PGE2) and thereby promoting inflammation and atherosclerotic lesion formation [34,46]. Here, PTGS2 is linked to metabolic syndrome.